黄芩素对人胃癌SGC7901细胞迁移及侵袭的影响及其作用机制

目的观察黄芩素对人胃癌SGC7901细胞迁移及侵袭的影响及其作用机制。方法以人胃癌SGC7901细胞为研究对象,分别加入20mL的培养液(对照组)或20mL(50、100、150mol/L)黄芩素溶液处理细胞48h,细胞划痕试验检测不同剂量黄芩素对人胃癌SGC7901细胞迁移的影响,Transwell侵袭实验检测黄芩素对细胞侵袭能力的改变;比色法检测细胞胰蛋白酶活性,用Western blot方法检测活化的蛋白酶激活受体-2(protease-activated receptor-2,PAR-2)蛋白表达水平,RT-PCR法检测基质金属蛋白酶-2(matrix metalloproteinases-2,MMP-2)mRNA及基质金属蛋白酶-9(matrix metalloproteinases-9,MMP-9)mRNA水平。结果与对照组比较,各治疗组人胃癌SGC7901细胞迁移及侵袭的能力、胰蛋白酶活性、活化的PAR-2、MMP-2 mRNA及MMP-9 mRNA表达水平均显著下降(P<0.05),呈剂量依赖性。活化的PAR-2与MMP-2mRNA及MMP-9 mRNA表达水平呈正相关关系(r=0.564,P<0.05;r=0.581,P<0.05)。结论 PAR-2活性、MMP-2及MMP-9mRNA表达与胃癌的发生、发展密切相关,活化的PAR-2可通过上调MMP-2及MMP-9 mRNA的表达而参与癌细胞迁移及侵袭,黄芩素能显著抑制人胃癌SGC7901细胞的PAR-2活性和MMP-2及MMP-9mRNA表达,从而降低癌细胞迁移及侵袭能力,这与其抑制胰蛋白酶活性有密切关系。     

HPLC法测定阳春滴丸中淫羊藿苷的含量

目的：通过试验摸索阳春滴丸的含量测定控制方法。方法：色谱柱：Hedra ODS-2（Size：250mm×4.6mm,Media：10nm5um）;乙腈：水（25：75）为流动相;流速0.8ml/min。检测波长270nm。结果：淫羊藿苷进样量在0.112~0.560μg之间与峰面积分值呈线性关系（r=0.9998）,平均加样回收率达98.85%。重复性试验RSD%值为0.55%。结论：所建方法可行,专属性、重复性好,可用于阳春滴丸的质量控制。     

HPLC法同时测定双黄连注射液中绿原酸、连翘苷、黄芩苷的含量

目的：建立同时测定双黄连注射液中绿原酸、连翘苷和黄芩苷的HPLC方法。方法：色谱柱为Agilent ZORBAXXDB C18柱（250mm×4.6mm,5μm）;流动相：甲醇-0.2%磷酸溶液,线性梯度洗脱,流速为1.0 mL/mi n,检测波长为324nm、280nm,柱温30℃。结果：绿原酸、连翘苷、黄芩苷的线性范围分别为0.093～1.860、0.022～0.440、0.328～6.560μg,三种成分的含量分别为绿原酸0.043mg/mL、连翘苷0.1 3mg/mL、黄芩苷7.90mg/mL。结论：该方法简便、快速、准确,可作为双黄连注射液的质量控制方法。     

5-氮胞苷对宫颈癌细胞系DAPK1异常甲基化的影响

目的　观察宫颈癌细胞系SiHa及HeLa中凋亡相关蛋白激酶 1(DAPK1)的表达与甲基化修饰之间的相关性,以及5 氮胞苷对细胞DAPK1表达和生长的影响。方法　应用甲基化特异性PCR法分析细胞中DAPK1的甲基化状态;采用RT- PCR及免疫组化SABC法检测不同浓度 5- 氮胞苷干预对宫颈癌细胞 DAPK1 mRNA及蛋白表达的影响;MTT法观察5 -氮胞苷对细胞增殖的影响。结果　DAPK1基因在宫颈癌细胞 SiHa中有甲基化修饰,5- 氮胞苷干预能使其甲基化的DAPK1基因重新表达并抑制细胞生长。结论　DAPK1 的甲基化修饰是宫颈癌发生重要机制之一,5 -氮胞苷能使甲基化的DAPK1去除甲基化修饰,重新表达并恢复抑癌作用。     

引阳素胶囊中淫羊藿苷的含量测定

目的建立引阳素胶囊中淫羊藿苷的高效液相色谱(HPLC)含量测定方法。方法采用HPLC法。色谱柱Li-chrospher C18(4.6 mm×250 mm,5μm),C18保护柱;流动相为乙腈-20 g/L冰醋酸水溶液(30∶70);检测波长270 nm;流速1.0 mL/min;柱温为室温;进样量10μL。样品加50%(体积分数)乙醇超声提取,浸提液过0.45μm滤膜后测定。结果淫羊藿苷线性范围为10.0-60.0 mg/L,回归方程为C=2.042×10-5A+0.554,r=0.9993,平均回收率为99.8%,RSD为0.65%。结论本法用于引阳素胶囊中淫羊藿苷的含量测定时简便快捷、准确。     

HPLC-MS/MS法测定兔血浆中黄芪甲苷的含量

目的 建立兔含药血浆中黄芪甲苷含量快速测定的新方法.方法 固相萃取法富集血浆中的黄芪甲苷;Agilent SB-C18反相色谱进行分离;采用离子阱质谱多级反应模式,以m/z 807.5→627.1为选择离子对,内标法测定含量.结果 血浆中黄芪甲苷的检测限为0.1ng/mL,线性范围为0.5～50.0μg/mL,平均方法回收率在96.3%～104.7%范围内.结论 该方法具有灵敏度高、稳定性好和快速的特点,符合生物样品的分析要求,有望用于黄芪甲苷的药代动力学研究.     

DETERMINATION OF POLYDATIN IN POLYGONUM CUSPIDTUM SIEB. ETZUCC. BY TLC-FLUORESCENCE SPECTROPHOTOMETRY

Objective A method of TLC-fluorescence spectrophotometry was established to assay the content of polydatin in polygonum cuspidatum sieb. et zucc. Methods: Polydatin was extracted by methanol and separated with ch‘loroform-acetone-formic acid-water (4:4:0.5:0.2) by thin layer chromatography. The excitation wavelength and emission wavelength were 284 nm and 384 nm, respectively. Results The linear regression equation of the calibrationgraph was y=7.02179x 4.5143, a linear regression correlative coefficient r= 0. 9936. Conclusion This method was proved simple, stable and sensitive. It can be used in quality control of herbs.     

LC-MS determination and pharmacokinetic study of salidroside in rat plasma after oral administration of suspensions of t

A simple,rapid and sensitive liquid chromatography-mass spectrometry（LC-MS）method was developed for the determination of salidroside in rat plasma and study of its pharmacokinetics after oral administration of suspension of Erzhi Wan and Fructus Ligustri     

高效液相色谱法测定舒肤胶囊中芍药苷的含量

目的采用HPLC法对处方中主要成分芍药苷进行含量测定。方法采用高效液相色谱法,以KromasilC18(250 mm×4.6 mm,5μm)为分析柱,流动相为乙腈-1.5 mL/L磷酸(12∶88),流速1 mL/min,检测波长230 nm,柱温为室温。结果芍药苷回归方程:Y=83 168X+72 569(r=0.999 5,n=6),芍药苷在0.06~0.18μg范围内线性关系良好;方法的平均回收率为100.21%,精密度RSD的值为1.31%。结论本方法操作简便、快速、准确、灵敏,适用于舒肤胶囊的质量控制。     

In situ absorption and metabolism of stilbene glycoside in rat

Stilbene glycoside (TSG) has been shown to have many beneficial properties. It is therefore essential to understand the absorption and metabolism of TSG in detail. We determined the recovery of TSG and its metabolites (TSG sulfate/glucuronides) in rat gastric contents, gastric mucosa, portal vein plasma, celiac arterial plasma, bile, and urine after administration of 15mg of TSG in 0.5mL physiological saline or incubation for 20min in situ in the stomach of rats. Within 20min, (64.0±9.8)% of the administered TSG disappeared from the stomach; later, TSG was recovered in both free and conjugated forms in plasma and bile, but not in urine. On the other hand, only free TSG was detected in the gastric contents and mucosa; it was also detected in the portal vein plasma as (48.1±3.5)% of the total TSG (all forms of TSG). However, the proportion of free TSG in the celiac arterial plasma and bile decreased to 4%-10%. In addition, the proportion of free TSG to total TSG in the liver microsome incubation mixture after TSG was incubated in liver microsome at 37℃ for 30min was very low [(10.6 ± 2.6)%]. These results indicate that TSG could be quickly absorbed from the rat stomach, conjugated in liver and excreted in bile. Such novel information would be helpful for the use of TSG as a beneficial natural product which may improve its proposed efficacy in preventing chronic diseases.